J. Krassowski

Exaggerated growth hormone response to growth hormone-releasing hormone in type I diabetes mellitus.

J. Felber, W. Jeske, S. Zgliczyński, 1988, Acta endocrinologica.

[Glucose tolerance in adrenocortical hyperfunction. Analysis of 100 cases].

A. Kasperlik-Załuska, J. Krassowski, M. Godziejewska, 1994, Polskie Archiwum Medycyny Wewnetrznej.

Short term pirenzepine treatment is ineffective in suppressing 24-h growth hormone secretion in type 1 diabetes mellitus.

P. Szulc, A. Makowska, W. Jeske, 1993, Diabetes research and clinical practice.

[The effect of growth hormone replacement therapy on markers of bone formation and bone mineral density in elderly men].

L. Papierska, J. Kozakowski, S. Zgliczyński, 1998, Polskie Archiwum Medycyny Wewnetrznej.

Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients.

M. Wiench, E. Gubała, B. Jarzab, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Estimation o f R isk o f I nherited M edullary T hyroid Carcinoma i n A pparent S poradic P atients

M. Wiench, E. Gubała, B. Jarzab, 2001 .

Comment of long-acting lanreotide inducing clinical and biochemical remission of acromegaly caused by disseminated GHRH secreting carcinoid.

W. Zgliczyński, W. Jeske, S. Zgliczyński, 1999, The Journal of clinical endocrinology and metabolism.

TRH-Induced Growth Hormone Release in Insulin-Dependent Diabetes Mellitus

W. Jeske, S. Zgliczyński, J. Krassowski, 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.